Healthcare
Live Price
Offline$6.18
+0.00% today
1Y Change
+19.08%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 252 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Photocure ASA (PHCUF) is a Healthcare stock with a market cap of $1.75B and listed on OTC. The stock last traded around $6.18 and up 19.1% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +1.3%, EPS growth of +68.1%, a dividend yield of 0.0%. What stands out right now is revenue +1.3%, EPS +68.1%, free cash flow -42.4% with operating margin 10.2% and ROIC 0.8%. Valuation is more restrained than many high-expectation growth names at price/sales 3.3. Stock Foundry combines PHCUF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PHCUF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PHCUF Max Drawdown
-16.37%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PHCUF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$360.5M
-8.3% YoY
FY Net Income
-$30.9M
+57.0% YoY
Free Cash Flow
$20.2M
+458.7% YoY
Revenue Growth
+1.3%
EPS Growth
+68.1%
Gross Margin
90.7%
Net Margin
-0.3%
Income statement
NOK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 532M | 525M | 501M | 393M | 361M |
| Gross Profit | 490M | 495M | 475M | 370M | 336M |
| Operating Income | 110M | 20M | 28M | -49M | 9M |
| EBITDA | 139M | 74M | 64M | -21M | 17M |
| Net Income | -2M | -5M | 979K | -72M | -31M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
NOK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 239M | 289M | 256M | 265M | 319M |
| Total Assets | 707M | 739M | 712M | 719M | 790M |
| Total Liabilities | 223M | 237M | 229M | 256M | 287M |
| Shareholder Equity | 484M | 500M | 483M | 463M | 503M |
| Total Debt | 0 | 17M | 34M | 54M | 79M |
| Net Debt | -239M | -272M | -223M | -210M | -240M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
24M
+1283.6% YoY
Capital Expenditures
4M
-2.6% YoY
Free Cash Flow
20M
+458.7% YoY
Key ratios
Gross Margin
90.7%
Operating Margin
10.2%
Net Margin
-0.3%
ROE
-0.3%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.